Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Supriya Lifescience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

₹603.3

2024-10-29

Market Capitalization

₹51.1 B

2024-10-29

Revenue

₹6.8 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue2.1B2.8B3.1B3.9B5.3B4.5B5.6B6.8B
Cost of goods sold1.4B1.5B1.4B1.3B2.0B1.9B2.4B2.2B
Gross profit701.8M1.3B1.7B2.6B3.3B2.7B3.3B4.7B
Gross profit margin, %46.7%55.4%66.5%62.8%59.9%59.1%68.6%
Operating expense total488.9M637.7M731.6M844.4M1.2B1.5B1.6B2.1B
Depreciation and amortization48.4M52.4M60.5M67.6M101.2M118.2M158.2M204.4M
EBITDA216.5M662.8M995.8M1.7B2.1B1.2B1.7B2.5B
EBITDA margin, %23.9%32.0%44.6%40.5%27.5%30.7%37.5%
EBIT223.4M649.0M1.0B1.7B2.0B1.1B1.6B2.3B
EBIT margin, %23.4%32.5%42.8%38.6%24.9%27.8%34.5%
Interest income3.7M6.2M21.7M49.9M70.8M95.1M83.5M40.1M
Interest expense106.7M98.0M61.3M40.8M42.0M30.8M51.5M18.1M
Pre tax profit156.9M573.3M967.5M1.7B2.1B1.2B1.7B2.5B
Income tax expense41.6M160.2M245.9M435.6M554.4M336.3M465.8M605.2M
Net Income115.4M413.1M721.6M1.2B1.5B898.6M1.2B1.9B

Footer menu